Dow Up0.00% Nasdaq Up0.09%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
20.28 Down 0.26(1.27%) Nov 28, 1:00PM EST
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate-0.35-0.37-1.32-1.41
No. of Analysts9.004.009.009.00
Low Estimate-0.38-0.41-1.34-1.86
High Estimate-0.33-0.33-1.29-0.87
Year Ago EPS-0.27-0.33-1.02-1.32
Revenue EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate400.00K270.00K2.50M1.44M
No. of Analysts9299
Low EstimateNaN160.00K2.11MNaN
High Estimate1.27M380.00K3.38M3.74M
Year Ago Sales620.00K416.00K4.11M2.50M
Sales Growth (year/est)-35.50%-35.10%-39.20%-42.40%
Earnings HistoryDec 13Mar 14Jun 14Sep 14
EPS Est-0.28-0.26-0.32-0.33
EPS Actual-0.27-0.33-0.32-0.31
Difference0.01-0.070.000.02
Surprise %3.60%-26.90%0.00%6.10%
EPS TrendsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Current Estimate-0.35-0.37-1.32-1.41
7 Days Ago-0.35-0.37-1.32-1.41
30 Days Ago-0.35-0.38-1.32-1.39
60 Days Ago-0.35-0.38-1.32-1.39
90 Days Ago-0.34-0.35-1.31-1.34
EPS RevisionsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0000
Up Last 30 Days1053
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstCLDXIndustrySectorS&P 500
Current Qtr.-29.60%N/A-69.40%18.70%
Next Qtr.-12.10%N/A-42.10%18.90%
This Year-29.40%N/A30.60%7.80%
Next Year-6.80%N/A21.60%10.70%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A14.39%14.40%9.81%
Price/Earnings (avg. for comparison categories)-15.56-11.054.6121.02
PEG Ratio (avg. for comparison categories)N/A10.643.743.21
Currency in USD.